Evidence map›Paper›PMID 26272203›Full record

ArticleGenome biology2015

Predicting chromatin organization using histone marks.

Jialiang Huang, Eugenio Marco, Luca Pinello, Guo-Cheng Yuan

Abstract read
In one paragraph

Article in Genome biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Machine and Deep Learning Methods for Predicting 3D Genome Organization.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Jialiang HuangDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. jhuang@jimmy.harvard.edu.
Eugenio MarcoDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. emarco@jimmy.harvard.edu.
Luca PinelloDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. lpinello@jimmy.harvard.edu.
Guo-Cheng YuanDepartment of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. gcyuan@jimmy.harvard.edu.

Funding

A guided approach to interrogating genome-wide chromatin interactionsR21HG006778 · NHGRI · DANA-FARBER CANCER INST · PI YUAN, GUO-CHENG · 2012 to 2013
$481k
Discovering disease-causal variants by linking genetic and epigenetic variationK99HG008399 · NHGRI · DANA-FARBER CANCER INST · PI PINELLO, LUCA · 2015 to 2016
$146k
Intramural NIH HHSNHGRI NIH HHS 5R21HG006778NHGRI NIH HHS K99 HG008399NHGRI NIH HHS R21 HG006778
6 · The paper itself

Abstract

Genome-wide mapping of three dimensional chromatin organization is an important yet technically challenging task. To aid experimental effort and to understand the determinants of long-range chromatin interactions, we have developed a computational model integrating Hi-C and histone mark ChIP-seq data to predict two important features of chromatin organization: chromatin interaction hubs and topologically associated domain (TAD) boundaries. Our model accurately and robustly predicts these features across datasets and cell types. Cell-type specific histone mark information is required for prediction of chromatin interaction hubs but not for TAD boundaries. Our predictions provide a useful guide for the exploration of chromatin organization.

Indexed as

Histone CodeCell LineChromatinChromatin ImmunoprecipitationComputer SimulationHigh-Throughput Nucleotide SequencingHumansRegulatory Sequences, Nucleic AcidSequence Analysis, DNAChromatin

Identifiers

PMID26272203
PMCPMC4549084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.